Filtered By:
Countries: France Health
This page shows you your search results in order of relevance. This is page number 20.
Order by Relevance | Date
Total 24739 results found since Jan 2013.
Use of mTOR inhibitors (rapalogs) for the treatment of skin changes in tuberous sclerosis complex
CONCLUSION: The issues of cost and access to affordable topical rapamycin formulations are critical for the patients even if skin changes do not cause serious harm in the context of TSC. We strongly suggest to improve and standardize the formulation of topical rapamycin, to encourage the pharmaceutical industry for providing commercial products, and the Health systems (social welfare) to reimburse them. © 2022 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved.PMID:36585067 | DOI:10.1016/S0929-693X(22)00286-X
Source: Archives de Pediatrie - December 30, 2022 Category: Pediatrics Authors: D Farges N Sigg D Ville L Martin Source Type: research
